Clario Holdings, Inc. acquired by Thermo Fisher Scientific
Thermo Fisher Scientific agreed to acquire Clario Holdings, Inc., a clinical trial services brand, on Oct 29, 2025.
Preliminary: The announcement date is not yet independently verified.
Transaction summary
- Target
- Clario Holdings, Inc.
- Acquirer
- Thermo Fisher Scientific
- Seller
- -
- Announced
- 2025-10-29(unverified)
- Geography
- -
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-07-13
- Latest update
- 2026-10-29
Value and multiples
100% enterprise value
Undisclosed
Value not disclosed
Basis: FundComb estimate
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Enterprise value is unavailable.
Source summary
Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights - Business Wire
ConfirmedBusiness Wire reported that Thermo Fisher Scientific announced an agreement to acquire Clario Holdings, Inc., a clinical trial services and technology business serving pharma and biotech customers.
Open sourceContinue your research
Related transaction comps
Element Materials Technology’s Life Sciences Testing Services Business in North America acquired by Eurofins
2026-07-20 · Confirmed
View transaction → Life SciencesClarivate Life Sciences & Healthcare segment acquired by Altaris LLC
2026-07-06 · Confirmed
View transaction → Life SciencesBio-Techne acquired by Merck KGaA, Darmstadt, Germany
2026-06-25 · Confirmed
View transaction → Life SciencesThermo Fisher Scientific’s microbiology business acquired by Astorg
2026-04-27 · Confirmed
View transaction →